Eastwood Bio-Medical Canada Inc. (TSXV:EBM)
Canada
· Delayed Price · Currency is CAD 0.620
-0.020 (-3.13%)
Mar 9, 2026, 12:25 PM EST
TSXV:EBM Income Statement
Financials in millions CAD. Fiscal year is November - October.
Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | 2020 - 2016 |
| Revenue | 0.78 | 0.7 | 0.87 | 1.3 | 0.98 | Upgrade
|
| Revenue Growth (YoY) | 11.39% | -19.11% | -33.22% | 32.49% | 36.57% | Upgrade
|
| Cost of Revenue | 0.23 | 0.25 | 0.32 | 0.4 | 0.52 | Upgrade
|
| Gross Profit | 0.55 | 0.45 | 0.55 | 0.9 | 0.46 | Upgrade
|
| Selling, General & Admin | 0.77 | 0.72 | 0.91 | 0.9 | 0.92 | Upgrade
|
| Amortization of Goodwill & Intangibles | 0.04 | 0.11 | 0.11 | 0.11 | 0.11 | Upgrade
|
| Operating Expenses | 0.82 | 0.84 | 1.02 | 1.01 | 1.03 | Upgrade
|
| Operating Income | -0.27 | -0.38 | -0.47 | -0.11 | -0.57 | Upgrade
|
| Interest Expense | - | -0.01 | -0.03 | -0.01 | -0 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.03 | -0.01 | -0.01 | -0.01 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.03 | -0.06 | -0.03 | -0.02 | -0.05 | Upgrade
|
| EBT Excluding Unusual Items | -0.33 | -0.46 | -0.55 | -0.15 | -0.62 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.02 | Upgrade
|
| Pretax Income | -0.33 | -0.46 | -0.55 | -0.15 | -0.6 | Upgrade
|
| Net Income | -0.33 | -0.46 | -0.55 | -0.15 | -0.6 | Upgrade
|
| Net Income to Common | -0.33 | -0.46 | -0.55 | -0.15 | -0.6 | Upgrade
|
| Shares Outstanding (Basic) | 69 | 69 | 69 | 69 | 69 | Upgrade
|
| Shares Outstanding (Diluted) | 69 | 69 | 69 | 69 | 69 | Upgrade
|
| EPS (Basic) | -0.00 | -0.01 | -0.01 | -0.00 | -0.01 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.01 | -0.01 | -0.00 | -0.01 | Upgrade
|
| Free Cash Flow | 0.02 | -0.02 | -0.02 | -0.01 | -0.12 | Upgrade
|
| Free Cash Flow Per Share | - | - | - | - | -0.00 | Upgrade
|
| Gross Margin | 70.45% | 64.72% | 63.18% | 69.45% | 46.72% | Upgrade
|
| Operating Margin | -34.13% | -54.24% | -54.42% | -8.60% | -58.07% | Upgrade
|
| Profit Margin | -42.55% | -64.93% | -62.98% | -11.53% | -61.52% | Upgrade
|
| Free Cash Flow Margin | 2.47% | -2.17% | -1.95% | -0.56% | -12.41% | Upgrade
|
| EBITDA | -0.22 | -0.33 | -0.42 | -0.06 | -0.52 | Upgrade
|
| EBITDA Margin | -28.38% | -47.43% | -48.87% | -4.97% | -53.42% | Upgrade
|
| D&A For EBITDA | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | Upgrade
|
| EBIT | -0.27 | -0.38 | -0.47 | -0.11 | -0.57 | Upgrade
|
| EBIT Margin | -34.13% | -54.24% | -54.42% | -8.60% | -58.07% | Upgrade
|
| Revenue as Reported | 0.78 | 0.7 | 0.87 | 1.3 | 0.98 | Upgrade
|
| Advertising Expenses | 0.02 | 0 | 0 | 0 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.